(UroToday.com) Dr. Andrea Alimonti summarized the results from two novel therapeutic strategies aimed at improving outcomes in men with castration-resistant prostate cancer. He began his talk by showing a published figure showing genomic and immune characteristics of tumors across the spectrum of disease as well as management strategies.